GlassScriptPhysician profile
Jerry D Dickess
NPI 1033697990
$2,120.24
in general payments reported to CMS, 2019-2025
13 companies · $19.64 in 2025
The $19.64 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,637 · 2022: $424 · 2023: $39.01 · 2025: $19.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $786.27 | 2021-2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $439.80 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $218.08 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.11 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $119.51 | 2022 | |
| Janssen Pharmaceuticals, INC | $91.63 | 2021-2022 | |
| Electromed, INC. | $91.42 | 2021 | |
| Jazz Pharmaceuticals INC. | $46.36 | 2021 | |
| Mylan Specialty L.P. | $45.39 | 2021 | |
| Genentech USA, INC. | $39.96 | 2021-2022 | |
| Genzyme Corporation | $31.10 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $27.97 | 2021 | |
| Amgen INC. | $19.64 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Dickess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.